Lam Research (NASDAQ:LRCX) Stock Price Down 1.6% – What’s Next?

Lam Research Corporation (NASDAQ:LRCX) fell 1.6% on Tuesday . The company traded as low as $263.71 and last traded at $273.38. 8,289,350 shares traded hands during trading, a decline of 24% from the average session volume of 10,977,290 shares. The stock had previously closed at $277.96.

Analyst Ratings Changes

A number of brokerages have weighed in on LRCX. Weiss Ratings downgraded Lam Research from a “buy (b)” rating to a “buy (b-)” rating in a research report on Thursday. UBS Group set a $300.00 price target on Lam Research in a research report on Thursday, January 29th. Deutsche Bank Aktiengesellschaft boosted their price target on Lam Research from $300.00 to $325.00 and gave the stock a “buy” rating in a research report on Thursday, April 23rd. Susquehanna boosted their price target on Lam Research from $350.00 to $385.00 and gave the stock a “positive” rating in a research report on Thursday, April 23rd. Finally, B. Riley Financial boosted their price target on Lam Research from $350.00 to $375.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Twenty-seven research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $292.97.

Lam Research Stock Down 1.6%

The firm has a 50-day moving average price of $247.50 and a 200 day moving average price of $211.98. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.54 and a quick ratio of 1.77. The company has a market cap of $341.88 billion, a price-to-earnings ratio of 51.58, a P/E/G ratio of 2.36 and a beta of 1.81.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 EPS for the quarter, beating the consensus estimate of $1.36 by $0.11. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The company had revenue of $5.84 billion for the quarter, compared to the consensus estimate of $5.70 billion. During the same quarter in the prior year, the business earned $1.04 earnings per share. The firm’s revenue for the quarter was up 23.8% on a year-over-year basis. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Sell-side analysts predict that Lam Research Corporation will post 5.67 EPS for the current year.

Insider Activity

In other news, CFO Douglas R. Bettinger sold 50,057 shares of the company’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total value of $11,214,269.71. Following the transaction, the chief financial officer owned 1,081,705 shares of the company’s stock, valued at approximately $242,334,371.15. This represents a 4.42% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Ava Harter sold 6,010 shares of the business’s stock in a transaction that occurred on Monday, April 27th. The shares were sold at an average price of $258.66, for a total value of $1,554,546.60. Following the completion of the sale, the insider owned 53,205 shares of the company’s stock, valued at approximately $13,762,005.30. This trade represents a 10.15% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 120,066 shares of company stock valued at $27,953,242. 0.31% of the stock is owned by insiders.

Institutional Investors Weigh In On Lam Research

Several institutional investors have recently made changes to their positions in LRCX. Norges Bank bought a new stake in shares of Lam Research in the fourth quarter valued at approximately $3,645,427,000. Price T Rowe Associates Inc. MD boosted its stake in shares of Lam Research by 352.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock valued at $2,344,347,000 after buying an additional 10,666,540 shares during the period. Arrowstreet Capital Limited Partnership boosted its stake in shares of Lam Research by 781.3% in the third quarter. Arrowstreet Capital Limited Partnership now owns 11,340,865 shares of the semiconductor company’s stock valued at $1,518,542,000 after buying an additional 10,053,978 shares during the period. Franklin Resources Inc. boosted its stake in shares of Lam Research by 57.0% in the fourth quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company’s stock valued at $1,730,724,000 after buying an additional 3,671,073 shares during the period. Finally, Corient Private Wealth LLC boosted its stake in shares of Lam Research by 235.5% in the fourth quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company’s stock valued at $890,040,000 after buying an additional 3,649,553 shares during the period. 84.61% of the stock is currently owned by institutional investors.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.